Press release, Helsinki, 2 October 2024 at 9 AM (EEST) Nexstim Receives NBS System 5 Order from European Customer Nexstim…
RICHMOND, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic…
Micro-Leads Pioneers Medical Breakthrough in a 20 Participant Human Study with HD64, the World's First Spine-ChipSOMERVILLE, MA / ACCESSWIRE /…
Series of ads encourage people to make the Sonicare Switch and upgrade from a manual toothbrush to a power toothbrush…
Following Colorado and Washington D.C., this expansion brings an additional seven million people into a new era of accessible and…
JERICHO, N.Y., Oct. 1, 2024 /PRNewswire/ -- The global consulting firm, proudly celebrating 50 transformative years, has gathered a curated collection…
KELOWNA, BC / ACCESSWIRE / October 1, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a…
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding…
SEATTLE and VANCOUVER, British Columbia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical…
Ocean Biomedical’s Anti-CHI3L1 patent coverage includes multiple methods of use for targeting a broad range of Cancers that include Lung…